Alexion shares tumble after drug misses trial goal
June 07, 2016 at 11:21 AM EDT
Shares of Alexion fell nearly 12 percent Monday after the pharmaceutical company said it missed its goal in a late-stage trial of the drug Solaris.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.